Seattle Genetics

ADCETRIS

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Seattle Genetics

Adcetris HCPCS:

J9042

HCPCS Code Descriptor:

Injection, brentuximab vedotin, 1 mg

Category:

J Code

Adcetris NDCs:

51144-0050-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Adcetris CPT Codes:

Potential CPT administration codes for Adcetris can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Adcetris:

ADCETRIS is an Oncology drug manufactured by Seattle Genetics and administered via the Intravenous route of administration. The J Code: J9042 is aligned to the drug ADCETRIS.

Adcetris is an antibody-drug conjugate that targets tumors expressing the CD30 antigen, a common tumor protein in certain types of lymphoma. Adcetris is administered as an intravenous infusion with the dosage and frequency of treatment dependent on the type and stage of the cancer being treated. Adcetris is co-marketed by both Millennium Pharmaceuticals and Seattle Genetics.

ACCESS PRICING AND MORE BY REGISTERING

J9042 Added Date:

January 1, 2013

J9042 Effective Date:

January 1, 2013

J9042 Termination Date:

HCPCS Active

Adcetris billing and coding information can be found through Seattle Genetics at the link below:
Adcetris patient assistance information can be found through The Seagen Secure Patient Assistance Program at the URL: https://www.seagensecure.com/patient/adcetris
ADCETRIS prescribing information can be found at the link below:
Information regarding ADCETRIS’s side effects can be found at MedlinePlus

BuyandBill.com Drug Alert: